Announced Mon, 27 Jul · 11:08 IST
Newspaper publication of Q1 FY27 unaudited financial results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹835.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.5—————————
Up moveDown movePending
AI summary
Mercury Laboratories filed newspaper publication of Q1 FY27 unaudited results for the quarter ended June 30, 2026 under SEBI rules, published in Active Times (English) and Mumbai Lakshdeep (Marathi). Total income was Rs 1596.32 lakhs versus Rs 1813.54 lakhs in Q1 FY26. Net profit after tax fell to Rs 29.78 lakhs from Rs 96.76 lakhs year-on-year. EPS dropped to Rs 2.48 from Rs 8.06. The company operates only in pharmaceuticals products.
Likely market impact
Routine SEBI compliance filing. However underlying Q1 results show sharp year-on-year decline with net profit after tax falling about 69 percent.